Combating the opioid epidemic in the United States

Article Page

Abstract

This editorial discusses the series of papers that feature initiatives to mitigate the opioid epidemic in the United States, and challenges encountered during the COVID-19 pandemic.

Keywords: COVID-19, epidemic, opioids, public health.

Citation: Pickard AS, Lee TA. Combating the opioid epidemic in the United States. Drugs Context. 2021;10:2021-10-7. https://doi.org/10.7573/dic.2021-10-7

Contributions: All authors contributed equally to the preparation of this review. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/11/dic.2021-10-7-COI.pdf

Acknowledgements: None.

Funding declaration: There was no funding associated with the preparation of this article.

Copyright: Copyright © 2021 Pickard AS, Lee TA. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Correct attribution: Copyright © 2021 Pickard AS, Lee TA. https://doi.org/10.7573/dic.2021-10-7. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0.

Article URL: https://www.drugsincontext.com/combating-the-opioid-epidemic-in-the-united-states

Correspondence: A Simon Pickard, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois Chicago, 833 South Wood St, M/C 886, Chicago, IL, 60612, USA. Email: pickard1@uic.edu

Provenance: Invited; externally peer reviewed.

Submitted: 25 October 2021; Accepted: 26 October 2021; Publication date: 15 December 2021.

Drugs in Context is published by BioExcel Publishing Ltd. Registered office: Plaza Building, Lee High Road, London, England, SE13 5PT.

BioExcel Publishing Limited is registered in England Number 10038393. VAT GB 252 7720 07.

For all manuscript and submissions enquiries, contact the Editorial office editorial@drugsincontext.com

For all permissions, rights and reprints, contact David Hughes david.hughes@bioexcelpublishing.com

Download free full text PDF